Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma

References

• AguileraGKissA1996Regulation of the hypothalamic-pituitary-adrenal axis and vasopressin secretion. Role of angiotensin IIAdv Exp Med Biol396105128726690
   PubMedGoogle Scholar
• AielloLPPierceEAFoleyED1995Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteinsProc Natl Acad Sci USA9210457617479819
   PubMed Web of Science ®Google Scholar
• AndersonDRDranceSMSchulzerMCollaborative Normal-Tension Glaucoma Study Group2001Natural history of normal-tension glaucomaOphthalmology1082475311158794
   PubMed Web of Science ®Google Scholar
• AraujoSVSpaethGLRothSM1995A ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomyOphthalmology102175399098274
   PubMed Web of Science ®Google Scholar
• BerkaJLStubbsAJWangDZ1995Renin-containing Müller cells of the retina display endocrine featuresInvest Ophthalmol Vis Sci36145087775123
   PubMed Web of Science ®Google Scholar
• BonomiLMarchiniGMarraffaM2000Vascular risk factors for primary open angle glaucoma: the Enga-Neumarkt StudyOphthalmology10712879310889099
   PubMed Web of Science ®Google Scholar
• BrandtCRPumferyAMMicalesB1994Renin mRNA is synthesized locally in rat ocular tissuesCurr Eye Res13755637531130
   PubMed Web of Science ®Google Scholar
• BrewsterUCSetaroJFPerazellaMA2003The rennin-angiotensinaldosterone system: cardiorenal effects and implications for renal and cardiovascular diseases statesAm J Med Sci326152412861121
   PubMed Web of Science ®Google Scholar
• BrownNJVaughanDE1998Angiotensin-converting enzyme inhibitionsCirculation971411209577953
   PubMed Web of Science ®Google Scholar
• CaoZKellyDJCoxA2000Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosisKidney Int5824375111115077
   PubMed Web of Science ®Google Scholar
• ChaturvediNSjolleAKStephensonJM1998Effect of lisinopril on progression of retinopathy in normotensive people with type I diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes MellitusLancet35128319433426
   PubMed Web of Science ®Google Scholar
• ChungOKuhlHStollM1998Physiological and pharmacological implications of AT1 versus AT2 receptorsKidney Int Suppl67S9599736262
   PubMed Web of Science ®Google Scholar
• Collaborative Normal-Tension Glaucoma Study Group1998aComparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressuresAm J Ophthalmol12648797
   PubMed Web of Science ®Google Scholar
• Collaborative Normal-Tension Glaucoma Study Group1998bThe effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucomaAm J Ophthalmol126498505
   PubMed Web of Science ®Google Scholar
• ConstadWHFiorePSamsonC1988Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucomaAm J Ophthalmol10567473287943
   PubMed Web of Science ®Google Scholar
• CrawfordKKaufmanPL1987Pilocarpine antagonizes prostaglandin F2α-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2αArch Ophthalmol1051112163477218
   PubMed Web of Science ®Google Scholar
• CugnoMAgostoniPMariD2005Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammationBr J Haematol1301132015982353
   PubMed Web of Science ®Google Scholar
• CulmanJHohleSQadriF1995Angiotensin as neuromodulator/neurotransmitter in central control of body fluid and electrolyte homeostasisClin Exp Hypertens17281937735275
   PubMed Web of Science ®Google Scholar
• DanserAHDerkxFHAdmiraalPJ1994Angiotensin levels in the eyeInvest Ophthalmol Vis Sci351008188125711
   PubMed Web of Science ®Google Scholar
• DranceSAndersonDRSchulzerMCollaborative Normal-Tension Glaucoma Study Group2001Risk factors for progression of visual field abnormalities in normal-tension glaucomaAm J Ophthalmol13169970811384564
   PubMed Web of Science ®Google Scholar
• DubeyRK1994Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal anterior smooth muscle cellsJ Pharm Exp Ther2694028
   Web of Science ®Google Scholar
• EhringTBaumgartDKrajcarM1994Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxideCirculation901368858087948
   PubMed Web of Science ®Google Scholar
• FlammerJHaefligerIOOrgulS1999Vascular dysregulation: a principal risk factor for glaucomatous damage?J Glaucoma8212910376264
   PubMed Web of Science ®Google Scholar
• ForetteFSeuxMLStaessenJA2002The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) studyArch Inter Med162204652
   PubMed Web of Science ®Google Scholar
• FunatsuHYamashitaHNakanishiY2002Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathyBr J Ophthalmol86311511864890
   PubMed Web of Science ®Google Scholar
• GargUCHassidA1989Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cellsJ Clin Invest83177472540223
   PubMed Web of Science ®Google Scholar
• GilbertREKrumHWilkinson-BerkaJ2003The rennin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerationDiabet Med206072112873287
   PubMed Web of Science ®Google Scholar
• GilbertREVranesDBerkaJL1998Vascular endothelial growth factor and its receptors in control and diabetic rat eyesLab Invest781017279714188
   PubMed Web of Science ®Google Scholar
• GoldsteinDEBlinderKJIdeCH1993Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Results of a 12-year longitudinal studyOphthalmology1001125318341491
   PubMed Web of Science ®Google Scholar
• GottfredsdottirMSAllinghamRRShieldsMB1997Physicians’ guide to interactions between glaucoma and systemic medicationsJ Glaucoma6377839407366
   PubMed Web of Science ®Google Scholar
• HaefligerIOFlammerJLüscherTF1992Nitric oxide and endothelium-1 are important regulators of human ophthalmic arteryInvest Ophthalmol Vis Sci33234031607246
   PubMed Web of Science ®Google Scholar
• HaefligerIOMeyerPFlammerJ1994The vascular endothelium as a regulator of the ocular circulation: A new concept in ophthalmology?Surv Ophthalmol39123327801220
   PubMed Web of Science ®Google Scholar
• HayrehSS1999The role of age and cardiovascular diseases in glaucomatous optic neuropathySurv Ophthalmol43S274210416745
   PubMed Web of Science ®Google Scholar
• HigginsRDYanYGengY2003Captopril and vascular endothelial growth factor in a mouse model of retinopathyCurr Eye Res27123914632165
   PubMed Web of Science ®Google Scholar
• HirookaKShiragaFHasegawaE2002Bradykinin sensitivity in primary open-angle glaucoma and normal-tension glaucoma patientsAm J Ophthalmol134922412470771
   PubMed Web of Science ®Google Scholar
• HirookaKBabaTFujimuraT2006Prevension of visual field defect progression with angiotensin-converting enzyme inhibitor in eyes with normal-tension glaucomaAm J Ophthalmol142523516935614
   PubMed Web of Science ®Google Scholar
• Hogeboom van BuggenumIMPolakBCReichert-ThoenJW2002Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathyDiabetologia45203911935151
   PubMed Web of Science ®Google Scholar
• HornigBDrexlerH1997Endothelial function and bradykinin in humansDrugs544279429844
   PubMed Web of Science ®Google Scholar
• IgicR1985Kallikrein and kininases in ocular tissuesExp Eye Res41117202993009
   PubMed Web of Science ®Google Scholar
• ItoMOliverioMIMannonPJ1995Regulation of blood pressure by the type 1A angiotensin II receptor geneProc Natl Acad Sci USA92352157724593
   PubMed Web of Science ®Google Scholar
• InoueTYokoyamaTKoikeH2003CS-088, an angiotensin type 1 receptor antagonist, ameliorated the impaired blood flow in the optic nerve head of rabbitOphthalmic Res35351414688427
   PubMed Web of Science ®Google Scholar
• KanellopoulosAJEricksonKANetlandPA1996Systemic calcium channel blockers and glaucomaJ Glaucoma5357628897236
   PubMed Web of Science ®Google Scholar
• KielJW1994Choroidal myogenic autoregulation and intraocular pressureExp Eye Res58529437925690
   PubMed Web of Science ®Google Scholar
• KohKKAhnJYHenSH2003Pleiotropic effects of angiotensin II receptor blocker in hypertensive patientsJ Am Coll Cardiol429051012957441
   PubMed Web of Science ®Google Scholar
• LevyBIBenessianoJHenrionD1996Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structureJ Clin Invest98418258755652
   PubMed Web of Science ®Google Scholar
• LiuSAraujoSVSpaethGL1996Lack of effect of calcium channel blockers on open-angle glaucomaJ Glaucoma5187908795757
   PubMed Web of Science ®Google Scholar
• LottiVJPawlowskiN1990Prostaglandins mediate the ocular hypotensive action of the angiotensin converting enzyme inhibitor MK-422 (enalaprilat) in African green monkeysJ Ocul Phalmacol617
   PubMed Web of Science ®Google Scholar
• MaJXSongQHatcherHC1996Expression and cellular localization of the kallikrein-kinin system in human ocular tissuesExp Eye Res6319268983960
   PubMed Web of Science ®Google Scholar
• ManciniGBHenryGCMacayaC1996Angiotensin-converting enzyme inhibitor with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) StudyCirculation94258658759064
   PubMed Web of Science ®Google Scholar
• MaoLKStewartWCShieldsMB1991Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucomaAm J Ophthalmol1115151985490
   PubMed Web of Science ®Google Scholar
• MeyerPFlammerJLüscherTF1993Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: Role of nitric oxide and endothelinsInvest Ophthalmol Vis Sci343614218258520
   PubMed Web of Science ®Google Scholar
• MeyerPFlammerJLüscherTF1995Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonistsInvest Ophthalmol Vis Sci36555627890486
   PubMed Web of Science ®Google Scholar
• MombouliJVVanhouttePM1995Kinins and endothelial control of vascular smooth muscleAnnu Rev Pharmacol Toxicol35679057598512
   PubMed Web of Science ®Google Scholar
• MoravskiCJKellyDJCooperME2000Retinal neovascularization is prevented by blockade of the renin-angiotensin systemHypertension36109910411116132
   PubMed Web of Science ®Google Scholar
• MorbidekkiLParentiAGiovannelliL1998B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effectsBr J Pharmacol1241286929720802
   PubMed Web of Science ®Google Scholar
• MullerDNFiebelerAParkJK2003Angiotensin II and endothelin induce inflammation and thereby promote hypertension-induced end-organ damageClin Nephrol60Suppl 1S21212940529
   PubMed Web of Science ®Google Scholar
• MurataMNakagawaMTakahashiS1997Expression and lacalization of angiotensin II type I receptor mRNA in rat ocular tissuesOphthalmologica21138469380359
   PubMed Web of Science ®Google Scholar
• NetlandPAChaturvediNDreyerEB1993Calcium channel blockers in the management of low-tension and open-angle glaucomaAm J Ophthalmol115608138488913
   PubMed Web of Science ®Google Scholar
• Nouri-MahdaviKBrigattiLWeitzmanM1995Outcomes of trabeculectomy for primary-open angle glaucomaOphthalmology102176099098275
   PubMed Web of Science ®Google Scholar
• NyborgNCNielsenPJPrietoD1990Angiotensin-II does not contract bovine retinal resistance arteries in vitroExp Eye Res50469742373150
   PubMed Web of Science ®Google Scholar
• OhruiTMatsuiTYamayaM2004Angiotensin-converting enzyme inhibitors and incidence of Alzheimer’s disease in JapanJ Am Geriatr Soc526495015066094
   PubMed Web of Science ®Google Scholar
• OkadaYYamanakaISakamotoT2001Increased expression of angiotensin-converting enzyme in retinas of diabetic ratsJpn J Ophthalmol455859111754899
   PubMed Web of Science ®Google Scholar
• OtaniATakagiHOhH2000Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytesInvest Ophthalmol Vis Sci411192910752960
   PubMed Web of Science ®Google Scholar
• QuigleyHANickellsRWKerriganLA1995Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosisInvest Ophthalmol Vis Sci36774867706025
   PubMed Web of Science ®Google Scholar
• RaidooDMRamchurrenNNaidooY1996Visualisation of bradykinin B2 receptors on human brain neuronsImmunopharmacology3310478856125
   PubMed Web of Science ®Google Scholar
• RajagopalanSHarrisonDG1996Reversing endothelial dysfunction with ACE inhibitors. A new trendCirculation9424038759059
   PubMed Web of Science ®Google Scholar
• RegoliDBarabeJ1980Pharmacology of bradykinin and related kininsPharmacol Rev321467015371
   PubMed Web of Science ®Google Scholar
• SarlosSRizkallaBMoravskiCJ2003Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietinAm J Pathol1638798712937129
   PubMed Web of Science ®Google Scholar
• SchmechelDEApoptosis in neurodegenerative diseasesHannunYABoustanyRMApoptosis in neurobiologyBoca Raton, FLCRC Press19992348
   Google Scholar
• SchrierRWEstacioROEalerA2002Effect of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokesKidney Int6110869711849464
   PubMed Web of Science ®Google Scholar
• SilvestreJSBergayaSTamaratR2001Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B2 receptor pathwayCirc Res896788311597990
   PubMed Web of Science ®Google Scholar
• SteigerwaltRDJrBelcaroGVLauroraG1998Ocular and orbital blood flow in patients with essential hypertension treated with trandolaprilRetina18539459869463
   PubMed Web of Science ®Google Scholar
• StrandgaardSPaulsonOB1992Regulation of cerebral blood flow in health and diseasesJ Cardiovasc Pharmacol19S89931382171
   PubMed Web of Science ®Google Scholar
• SuzumaIHataYClermontA2001Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertensionDiabetes504445411272159
   PubMed Web of Science ®Google Scholar
• TakedaHKimuraYHigashidaH1999Localization of B2 bradykinin receptor mRNA in the rat retina and sclerocorneaImmunophalmacology45515
   Web of Science ®Google Scholar
• The EUCLID Study Group1997Randomized placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuriaLancet3491787929269212
   PubMed Web of Science ®Google Scholar
• TomitaKAraieMTamakiY1999Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjectsInvest Ophthalmol Vis Sci4011445110235547
   PubMed Web of Science ®Google Scholar
• TzourioCAndersonCChapmanN2003Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular diseaseArch Inter Med163106975
   PubMed Web of Science ®Google Scholar
• WagnerJJan DanserAHDerkxFH1996Demonstration of rennin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular rennin-angiotensin systemBr J Ophthalmol80159638814748
   PubMed Web of Science ®Google Scholar
• Wheeler-SchillingTHKohlerKSautterM1999Angiotensin II receptor subtype gene expression and cellular localization in the retina and non-neuronal ocular tissues of the ratEur J Neurosci1133879410564346
   PubMed Web of Science ®Google Scholar
• YamauchiTKashiiSYasuyoshiH2003Mitochondrial ATP-sensitive potassium channel: a novel site for neuroprotectionInvest Ophthalmol Vis Sci442750612766083
   PubMed Web of Science ®Google Scholar
• YaoKTschudiMFlammerJ1991Endothelium-dependent regulation of vascular tone of the porcine ophthalmic arteryInvest Ophthalmol Vis Sci32179182032802
   PubMed Web of Science ®Google Scholar
• YasuyoshiHKashiiSZhangS2000Protective effect of bradykinin against glutamate neurotoxicity in cultured rat retinal neuronsInvest Ophthalmol Vis Sci412273810892873
   PubMed Web of Science ®Google Scholar
• YolesESchwartzM1998Potential neuroprotective therapy for glaucomatous optic neuropathySurv Ophthalmol42367729493279
   PubMed Web of Science ®Google Scholar
• YoshijiHKuriyamaSFukuiH2002Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic atrategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factorTumor Biol2334856
   PubMed Web of Science ®Google Scholar
• YoshijiHKuriyamaSKawataM2001The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factorClin Cancer Res71073811309359
   PubMed Web of Science ®Google Scholar
• YusufSSleightPPogueJ2000Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study InvestigatorsN Engl J Med3421455310639539
   PubMed Web of Science ®Google Scholar
• ZouYAkazawaHQinY2004Mechanical stress activates angiotensin II type 1 receptor wiithout the involvement of angiotensin IINat Cell Biol649950615146194
   PubMed Web of Science ®Google Scholar